A few of top 20 pathways including vantveer breast cancer poor prognosis, Xu hgf signature not via AKT1 48HR and vantveer breast cancer metastasis were markedly more activated in the high‐risk patients than that in low‐risk patients (Figure 5A). This evidence concerns the gene AKT1 and breast carcinoma.